Company Filing History:
Years Active: 2025
Title: Griffin Haas: Innovator in Influenza Vaccine Development
Introduction
Griffin Haas is a notable inventor based in New York, NY (US). He has made significant contributions to the field of vaccine development, particularly in the area of influenza viruses. His innovative work focuses on creating a safer and more effective vaccine platform.
Latest Patents
Griffin Haas holds a patent for "Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same." This invention provides a modified influenza A virus (IAV) that includes at least one artificial gene segment with a duplicated packaging signal. The result is a modified IAV that is replication competent and avirulent. When co-infected with a wild type virus, it leads to segment exchange, compromising the spread of both viruses. This invention also outlines methods for making and using these IAVs in the treatment and prevention of influenza-related diseases. He has 1 patent to his name.
Career Highlights
Griffin Haas is affiliated with Duke University, where he continues to advance research in the field of virology and vaccine development. His work is crucial in addressing public health challenges posed by influenza viruses.
Collaborations
Griffin collaborates with esteemed colleagues such as Nicholas Scott Heaton and Alfred Theodore Harding. Their combined expertise enhances the research efforts in developing effective influenza vaccines.
Conclusion
Griffin Haas is a dedicated inventor whose work in influenza vaccine development is paving the way for innovative solutions in public health. His contributions are vital in the ongoing fight against influenza-related diseases.